রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন*

Indications:

• Prevention of invasive pneumococcal disease caused by 13 serotypes of Streptococcus pneumoniae

• Prevention of pneumonia, meningitis, and sepsis in infants, children, adults, and immunocompromised patients

• Recommended for infants, toddlers, older adults, and at-risk populations

Pharmacology:
PREVENAR 13 contains purified capsular polysaccharides from 13 pneumococcal serotypes conjugated to a carrier protein (CRM197). This conjugation elicits a strong immune response and helps produce protective antibodies against pneumococcal infections.

Dosage:

• Single 0.5 mL dose administered intramuscularly

• Schedule depends on age and clinical condition; often given in a series for infants and young children

Administration:

• Administer by deep intramuscular injection, typically in the deltoid muscle or anterolateral thigh

• Should be given by healthcare professionals trained in vaccine administration

• Avoid intravenous or subcutaneous injection

Interaction:

• Can be co-administered with other routine vaccines at separate injection sites

• No significant adverse interactions reported

Contraindications:

• Hypersensitivity to any vaccine component

• Severe allergic reaction to a previous pneumococcal conjugate vaccine dose

Side Effects:

• Common: pain, redness, swelling at injection site

• Systemic: fever, irritability, fatigue

• Rare allergic reactions: rash, anaphylaxis (very rare)

Pregnancy & Lactation:

• Use only if clearly needed during pregnancy; data limited

• Considered safe during breastfeeding

Precautions & Warnings:

• Inform healthcare provider of any allergies or previous vaccine reactions

• Monitor for adverse events following immunization

• Not used for treatment of active pneumococcal infections

Therapeutic Class:
Vaccines, Pneumococcal Conjugate Vaccine

Storage Conditions:

• Store refrigerated at 2°C to 8°C

• Do not freeze

• Protect from light

• Use before expiry date